Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
34.64
-0.07 (-0.20%)
At close: Aug 31, 2026, 4:00 PM EDT
34.40
-0.24 (-0.69%)
Pre-market: Sep 1, 2026, 4:32 AM EDT
Roivant Sciences Market Cap
Roivant Sciences has a market cap or net worth of $25.02 billion as of August 31, 2026. Its market cap has increased by 207.13% in one year.
Market Cap
25.02B
Enterprise Value
21.29B
1-Year Change
207.13%
Ranking
Category
Stock Price
$34.64
ChartMarket Cap Chart
Since December 8, 2020, Roivant Sciences's market cap has increased from $533.38M to $25.02B, an increase of 4,591.11%. That is a compound annual growth rate of 95.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 31, 2026 | 25.02B | 65.79% |
| Dec 31, 2025 | 15.09B | 75.25% |
| Dec 31, 2024 | 8.61B | -4.61% |
| Dec 29, 2023 | 9.03B | 55.76% |
| Dec 30, 2022 | 5.80B | -18.13% |
| Dec 31, 2021 | 7.08B | 1,257.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Revolution Medicines | 44.08B |
| BeOne Medicines AG | 41.70B |
| Royalty Pharma | 34.99B |
| Alnylam Pharmaceuticals | 31.63B |
| Insmed | 25.89B |
| BioNTech SE | 25.64B |
| Incyte | 25.21B |
| Genmab | 19.98B |